Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Buy as much as you can... big news coming!

<< Previous

Bullboard Posts

Next >>

Comment by Chritterson Feb 25, 2021 10:11am

104 Views

Post# 32657076

RE:RE:Buy as much as you can... big news coming!

Thought you didnt buy it anymore? Now your pumping it again. Make up your mind.

Maui527 wrote: Yes...pump pump...bash bash...I dont care anymore...I just want the Freaking shares to start trading again!!!! Enough already!!!!! (Not you, the company)

I talked to Rob again last week, and same old song about the OSC delays...I don't buy it anymore!!!!

He should never have put the company in this position to start with!!!

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?